Skip to main content

Site notifications

Notice for enasidenib (Celgene Pty Ltd)

Active ingredients
enasidenib
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Haematology

Help us improve this page